C C Carson

Summary

Affiliation: University of North Carolina
Country: USA

Publications

  1. ncbi request reprint The epidemiology, anatomy, physiology, and treatment of erectile dysfunction in chronic renal failure patients
    C C Carson
    Department of Surgery, University of North Carolina at Chapel Hill, USA
    Adv Ren Replace Ther 6:296-309. 1999
  2. ncbi request reprint Carcinoma of the prostate: overview of the most common malignancy in men
    Culley C Carson
    Division of Urology, Department of Surgery, School of Medicine, UNC, Chapel Hill 27599 7235, USA
    N C Med J 67:122-7. 2006
  3. ncbi request reprint Combination of phosphodiesterase-5 inhibitors and alpha-blockers in patients with benign prostatic hyperplasia: treatments of lower urinary tract symptoms, erectile dysfunction, or both?
    Culley C Carson
    University of North Carolina, Chapel Hill, North Carolina, USA
    BJU Int 97:39-43; discussion 44-5. 2006
  4. ncbi request reprint Cardiac safety in clinical trials of phosphodiesterase 5 inhibitors
    Culley C Carson
    University of North Carolina School of Medicine at Chapel Hill, North Carolina 27599 7235, USA
    Am J Cardiol 96:37M-41M. 2005
  5. ncbi request reprint Long-term use of sildenafil
    Culley C Carson
    University of North Carolina School of Medicine, Chapel Hill 27599 7000, USA
    Expert Opin Pharmacother 4:397-405. 2003
  6. ncbi request reprint The role of dihydrotestosterone in benign prostatic hyperplasia
    Culley Carson
    Division of Urology, Department of Medicine, University of North Carolina, Chapel Hill, North Carolina 27599 7235, USA
    Urology 61:2-7. 2003
  7. ncbi request reprint Sildenafil: a 4-year update in the treatment of 20 million erectile dysfunction patients
    Culley C Carson
    Division of Urology, School of Medicine, University of North Carolina at Chapel Hill, 427 Burnet Womack Bldg, Campus Box 7235, Chapel Hill, NC 27599 7235, USA
    Curr Urol Rep 4:488-96. 2003
  8. ncbi request reprint Erectile dysfunction and treatment of carcinoma of the prostate
    Culley C Carson
    Division of Urology, University of North Carolina, 2140 Bioinformatics Bldg CB 7235, Chapel Hill, NC 27599 7235, USA
    Curr Urol Rep 6:461-9. 2005
  9. ncbi request reprint Phosphodiesterase type 5 inhibitors for erectile dysfunction
    Culley C Carson
    Department of Surgery, Division of Urology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
    BJU Int 96:257-80. 2005
  10. ncbi request reprint Role of fluoroquinolones in the treatment of serious bacterial urinary tract infections
    Culley Carson
    Division of Urology, University of North Carolina, CB 7235, Chapel Hill, NC 27599 7235, USA
    Drugs 64:1359-73. 2004

Collaborators

Detail Information

Publications58

  1. ncbi request reprint The epidemiology, anatomy, physiology, and treatment of erectile dysfunction in chronic renal failure patients
    C C Carson
    Department of Surgery, University of North Carolina at Chapel Hill, USA
    Adv Ren Replace Ther 6:296-309. 1999
    ..The purpose of this article is to assist the nephrology interdisciplinary team in the management of ED by reviewing possible causes, available studies, and treatment options for their patients...
  2. ncbi request reprint Carcinoma of the prostate: overview of the most common malignancy in men
    Culley C Carson
    Division of Urology, Department of Surgery, School of Medicine, UNC, Chapel Hill 27599 7235, USA
    N C Med J 67:122-7. 2006
  3. ncbi request reprint Combination of phosphodiesterase-5 inhibitors and alpha-blockers in patients with benign prostatic hyperplasia: treatments of lower urinary tract symptoms, erectile dysfunction, or both?
    Culley C Carson
    University of North Carolina, Chapel Hill, North Carolina, USA
    BJU Int 97:39-43; discussion 44-5. 2006
    ..Although placebo-controlled studies are needed to confirm the impact of these drugs, alone or combined, on both ED and LUTS, this reinforces the need for a common approach to managing these two highly prevalent and bothersome conditions...
  4. ncbi request reprint Cardiac safety in clinical trials of phosphodiesterase 5 inhibitors
    Culley C Carson
    University of North Carolina School of Medicine at Chapel Hill, North Carolina 27599 7235, USA
    Am J Cardiol 96:37M-41M. 2005
    ..PDE5 inhibitors are effective in treating ED, and their safety profile is excellent. There do not appear to be significant cardiovascular safety issues in the man with satisfactory cardiac and performance status...
  5. ncbi request reprint Long-term use of sildenafil
    Culley C Carson
    University of North Carolina School of Medicine, Chapel Hill 27599 7000, USA
    Expert Opin Pharmacother 4:397-405. 2003
    ..With the use of sildenafil, it has been clearly, clinically demonstrated that the selective inhibition of PDE5 is an appropriate, effective, safe method for the treatment of ED of all aetiologies and severities...
  6. ncbi request reprint The role of dihydrotestosterone in benign prostatic hyperplasia
    Culley Carson
    Division of Urology, Department of Medicine, University of North Carolina, Chapel Hill, North Carolina 27599 7235, USA
    Urology 61:2-7. 2003
    ..The availability of dutasteride, the first dual (Type 1/Type 2) 5alpha-reductase inhibitor, offers the opportunity for rapid and consistent inhibition of DHT...
  7. ncbi request reprint Sildenafil: a 4-year update in the treatment of 20 million erectile dysfunction patients
    Culley C Carson
    Division of Urology, School of Medicine, University of North Carolina at Chapel Hill, 427 Burnet Womack Bldg, Campus Box 7235, Chapel Hill, NC 27599 7235, USA
    Curr Urol Rep 4:488-96. 2003
    ..Sildenafil has been safe and effective in patients taking various medications including multiple antihypertensive drugs, selective serotonin reuptake inhibitors, cardiac, and diabetic medications...
  8. ncbi request reprint Erectile dysfunction and treatment of carcinoma of the prostate
    Culley C Carson
    Division of Urology, University of North Carolina, 2140 Bioinformatics Bldg CB 7235, Chapel Hill, NC 27599 7235, USA
    Curr Urol Rep 6:461-9. 2005
    ..Combination medical therapy and surgical penile prosthesis implantation also are options for patients who do not respond to oral PDE-5 inhibitors...
  9. ncbi request reprint Phosphodiesterase type 5 inhibitors for erectile dysfunction
    Culley C Carson
    Department of Surgery, Division of Urology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
    BJU Int 96:257-80. 2005
    ..Other PDE5Is offering further potential improvements are under active investigation...
  10. ncbi request reprint Role of fluoroquinolones in the treatment of serious bacterial urinary tract infections
    Culley Carson
    Division of Urology, University of North Carolina, CB 7235, Chapel Hill, NC 27599 7235, USA
    Drugs 64:1359-73. 2004
    ..Physicians should choose empirical therapy based on patient demographics/medical history, presumed aetiology and local resistance patterns until more definitive guidelines become available...
  11. ncbi request reprint PNU-83757: a new agent for the treatment of erectile dysfunction
    Culley C Carson
    Division of Urology, University of North Carolina, Chapel Hill, 27599 7235, USA
    Curr Urol Rep 3:465-6. 2002
  12. ncbi request reprint The efficacy of sildenafil citrate (Viagra) in clinical populations: an update
    Culley C Carson
    Department of Surgery, Division of Urology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599 7235, USA
    Urology 60:12-27. 2002
    ..Findings from published accounts of sildenafil use in the clinical practice setting further demonstrated that sildenafil is an effective treatment for a wide range of patients with ED...
  13. ncbi request reprint Erectile dysfunction in the 21st century: whom we can treat, whom we cannot treat and patient education
    C C Carson
    Division of Urology, University of North Carolina, Chapel Hill, North Carolina 27599 7235, USA
    Int J Impot Res 14:S29-34. 2002
    ..If initial treatment modalities fail, more invasive alternatives or combination therapy should be offered to cure the patient's erectile dysfunction...
  14. ncbi request reprint Phosphodiesterase type 5 inhibitors: state of the therapeutic class
    Culley C Carson
    Division of Urology, Department of Surgery, University of North Carolina, Chapel Hill, NC, USA
    Urol Clin North Am 34:507-15, vi. 2007
    ..This discussion summarizes some of the current data on PDE5 inhibitors and their efficacy, safety, and use in other conditions...
  15. ncbi request reprint Distal penile prosthesis extrusion: treatment with distal corporoplasty or Gortex windsock reinforcement
    C C Carson
    University of North Carolina, Division of Urology, Chapel Hill 27599 7235, USA
    Int J Impot Res 14:81-4. 2002
    ..Outcomes with distal corporoplasty result in better function, less pain, and fewer recurrences than Gortex windsock repair...
  16. ncbi request reprint Erectile dysfunction: evaluation and new treatment options
    Culley C Carson
    Division of Urology, School of Medicine, University of North Carolina at Chapel Hill, 427 Burnet Womack Building, Campus Box 7235, Chapel Hill, NC 27599 7235, USA
    Psychosom Med 66:664-71. 2004
    ..This erectile dysfunction has substantial impact on interaction with their partners, families, and employment. ED may be a harbinger of more serious vascular events and is commonly associated with depression...
  17. ncbi request reprint Oral and injectable medications for the treatment of erectile dysfunction
    C C Carson
    University of North Carolina, Division of Urology, 427 Burnett Womack CB 7235, Chapel Hill, NC 27599 7235, USA
    Curr Urol Rep 1:307-12. 2000
    ..We can expect these oral agents, assisted by topical and injectable agents, to successfully restore erectile function in the majority of men suffering from erectile dysfunction...
  18. ncbi request reprint The efficacy and safety of tadalafil: an update
    C C Carson
    Department of Surgery, Division of Urology, University of North Carolina, Chapel Hill, NC, USA
    BJU Int 93:1276-81. 2004
    ..To provide an update on the efficacy and safety of tadalafil, a phosphodiesterase-5 inhibitor, in the treatment of erectile dysfunction (ED)...
  19. ncbi request reprint Ejaculatory dysfunction: progress in a rarely recognized sexual problem
    C C Carson
    University of North Carolina, Department of Urology, Chapel Hill, NC 27599 7235, USA
    Int J Impot Res 18:S3-4. 2006
  20. ncbi request reprint Antibiotic impregnation of inflatable penile prostheses: effect on perioperative infection
    Culley Carson
    University of North Carolina, Chapel Hill, NC 27599 7235, USA
    Expert Rev Med Devices 1:165-7. 2004
  21. ncbi request reprint Penile prosthesis implantation and infection for Sexual Medicine Society of North America
    C C Carson
    University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA
    Int J Impot Res 13:S35-8. 2001
    ..While penile prosthesis infection continues to be a dreaded complication, early diagnosis and aggressive surgical treatment may salvage the majority of these implants...
  22. ncbi request reprint Diagnosis, treatment and prevention of penile prosthesis infection
    C C Carson
    Division of Urology, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA
    Int J Impot Res 15:S139-46. 2003
    ..Implanting urologists must be familiar prophylaxis, avoidance, and treatment of penile prosthesis infections...
  23. ncbi request reprint Physician-patient dialogue and clinical evaluation of erectile dysfunction
    J Chun
    Division of Urology, University of North Carolina, Chapel Hill, North Carolina, USA
    Urol Clin North Am 28:249-58, viii. 2001
    ..The goal of evaluation is to find the appropriate treatment for the individual, dictated primarily by factors like the patients' preferences, comfort, cost, and the availability of treatment modalities...
  24. ncbi request reprint A comparison of dermal and cadaveric pericardial grafts in the modified Horton-Devine procedure for Peyronie's disease
    J L Chun
    University of North Carolina, Chapel Hill, North Carolina, USA
    J Urol 166:185-8. 2001
    ..Longer followup and larger patient series are needed to confirm the advantages of cadaveric pericardium...
  25. ncbi request reprint Penile prostheses: are they still relevant?
    C C Carson
    Division of Urology, University of North Carolina, NC, USA
    BJU Int 91:176-7. 2003
  26. ncbi request reprint Phase II trial of celecoxib in prostate-specific antigen recurrent prostate cancer after definitive radiation therapy or radical prostatectomy
    Raj S Pruthi
    Division of Urologic Surgery, Department of Biostatistics, and Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
    Clin Cancer Res 12:2172-7. 2006
    ..However, human trials are absent. This study evaluated the efficacy of the COX-2 inhibitor celecoxib in prostate-specific antigen (PSA) recurrent prostate cancer after radiation therapy (X-ray therapy or XRT) or radical prostatectomy...
  27. ncbi request reprint The efficacy, safety and tolerability of intracavernous PNU-83757 for the treatment of erectile dysfunction
    Ralph N Vick
    Division of Urology, Department of Surgery, University of North Carolina, Chapel Hill, NC, USA
    J Urol 167:2618-23. 2002
    ..We determined the efficacy, safety and tolerability of the erectogenic potassium channel opener PNU-83757...
  28. ncbi request reprint Urologic manifestations of hematologic disease sickle cell, leukemia, and thromboembolic disease
    Joseph A Molitierno
    Division of Urology, 428 Burnett Womack Building, CB7235, University of North Carolina Medical Center, Chapel Hill, NC 27599, USA
    Urol Clin North Am 30:49-61. 2003
    ..It is our duty to educate ourselves about these disease processes so that we can make the best clinical decisions for our patients...
  29. ncbi request reprint PDE5 inhibitors: are there differences?
    Culley C Carson
    Division of Urology, University of North Carolina, Chapel Hill, North Carolina 27759 7235, USA
    Can J Urol 13:34-9. 2006
    ..This discussion summarizes some of the current data on PDE5 inhibitors and their efficacy, safety, and use in other conditions...
  30. ncbi request reprint Vascular risk factors for erectile dysfunction
    Culley C Carson
    J Urol 178:2250-1. 2007
  31. ncbi request reprint Tolerance to the therapeutic effect of tadalafil does not occur during 6 months of treatment: A randomized, double-blind, placebo-controlled study in men with erectile dysfunction
    Chris G McMahon
    Australian Centre for Sexual Health, Sydney, Australia
    J Sex Med 3:504-11. 2006
    ..Tolerance can cause a decrease in drug efficacy during chronic therapy, possibly leading to treatment failures...
  32. ncbi request reprint Therapeutic strategies for managing erectile dysfunction: a step-care approach
    Culley C Carson
    Division of Urology, School of Medicine, University of North Carolina at Chapel Hill, 427 Burnet Womack Bldg, Campus Box 7235, Chapel Hill, NC 27599 7235, USA
    J Am Osteopath Assoc 102:S12-8. 2002
    ..This article reviews all treatment strategies for erectile dysfunction, with a focus on PDE5 inhibitors, including novel agents that may optimize patient outcomes...
  33. ncbi request reprint Re: Long-term efficacy of sildenafil and tachyphylaxis effect
    Culley C Carson
    J Urol 168:205. 2002
  34. ncbi request reprint A prospective study of the beneficial effects of dose optimization and customized instructions on patient satisfaction with sildenafil citrate (Viagra) for erectile dysfunction
    Andrew R McCullough
    Department of Urology, New York University School of Medicine, New York, New York 10016, USA
    Urology 68:38-46. 2006
    ..These results were enhanced with dose optimization, individual patient counseling, and customized instructions...
  35. ncbi request reprint Impact of race, age, income, and residence on prostate cancer knowledge, screening behavior, and health maintenance in siblings of patients with prostate cancer
    Raj S Pruthi
    Division of Urologic Surgery, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA
    Eur Urol 50:64-9. 2006
    ....
  36. ncbi request reprint Erectile response to vardenafil in men with a history of nonresponse to sildenafil: a time-from-dosing descriptive analysis
    Dimitrios G Hatzichristou
    Center for Sexual and Reproductive Health, Aristotle University of Thessaloniki, Thessaloniki, Greece
    Clin Ther 27:1452-61. 2005
    ..The efficacy and tolerability of vardenafil hydrochloride in men with erectile dysfunction (ED) and a history of nonresponse to sildenafil citrate have previously been reported...
  37. ncbi request reprint Cyclooxygenase-2 inhibitors and other NSAIDs in urology: current peril or future promise?
    Raj S Pruthi
    Division of Urologic Surgery, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA
    Urology 68:917-23. 2006
  38. ncbi request reprint Surgical alternatives for treating Peyronie's disease
    Chris K Tornehl
    Division of Urology, The University of North Carolina at Chapel Hill, NC, USA
    BJU Int 94:774-83. 2004
  39. doi request reprint Commentary on apomorphine versus sildenafil for erectile dysfunction
    Culley C Carson
    J Urol 179:S95-6. 2008
  40. ncbi request reprint Erectile response with vardenafil in sildenafil nonresponders: a multicentre, double-blind, 12-week, flexible-dose, placebo-controlled erectile dysfunction clinical trial
    Culley C Carson
    School of Medicine, University of North Carolina, Chapel Hill, NC 27599 7235, USA
    BJU Int 94:1301-9. 2004
    ..To evaluate the efficacy of vardenafil in patients previously unresponsive to sildenafil...
  41. ncbi request reprint Laboratory evaluation of the patient with erectile dysfunction
    Sean P McLaughlin
    Department of Surgery, Division of Urology, University of North Carolina, Chapel Hill, NC 27599 7235, USA
    Endocrine 23:113-7. 2004
    ....
  42. ncbi request reprint Urinary tract infections in women
    Sean P McLaughlin
    Division of Urology, Department of Surgery, University of North Carolina Hospitals, 2140 Bioinformatics Building, Campus Box 7235, Chapel Hill, NC 27599 7235, USA
    Med Clin North Am 88:417-29. 2004
    ..Response to therapy should govern the need for additional treatment. Certain motivated patients with three or more UTIs per year should be considered for prophylaxis therapy...
  43. ncbi request reprint Medical management of benign prostatic hypertrophy
    Jeffrey W Nix
    Division of Urology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599 7235, USA
    Can J Urol 14:53-7. 2007
    ..PDE 5 inhibitors, while effective in relieving LUTS symptoms, have not shown effectiveness in reducing post void residual volumes or increasing urinary flow rates...
  44. ncbi request reprint Central nervous system-acting agents and the treatment of erectile and sexual dysfunction
    Culley C Carson
    Division of Urology, School of Medicine, University of North Carolina at Chapel Hill, 2140 Bioinformatics Building, Chapel Hill, NC 27599, USA
    Curr Urol Rep 8:472-6. 2007
    ..Further, development of selective dopamine receptor agonists, melatonin agonists, and other CNS stimulatory or inhibitory agents may lead to improved treatment of sexual dysfunction in men and women...
  45. ncbi request reprint Penile prosthesis implantation: surgical implants in the era of oral medication
    Culley C Carson
    Division of Urology, Department of Surgery, University of North Carolina Chapel Hill, 2140 Bioinformatics Building, CB 7235, Chapel Hill, NC 27599 7235, USA
    Urol Clin North Am 32:503-9, vii. 2005
    ..Complications of these multipiece prostheses continue to decline, and patient satisfaction rates, tolerability, and longevity continue to increase...
  46. ncbi request reprint Adult circumcision outcomes study: effect on erectile function, penile sensitivity, sexual activity and satisfaction
    Kenneth S Fink
    Robert Wood Johnson Clinical Scholars Program and Division of Urology, School of Medicine, and the Department of Health Behavior and Health Education, School of Public Health, University of North Carolina at Chapel Hill, USA
    J Urol 167:2113-6. 2002
    ..We examine sexual function outcomes in men who have experienced sexual intercourse in the uncircumcised and circumcised states...
  47. ncbi request reprint Androgen deficiency in the aging male: a guide to diagnosis and testosterone replacement therapy
    Mathew C Raynor
    Department of Urology, Tulane University Health Sciences Center, New Orleans, LA, USA
    Can J Urol 14:63-8. 2007
    ..This should help clinicians better identify those patients in whom testosterone replacement therapy should be considered...
  48. ncbi request reprint Acute and chronic dosing of Lepidium meyenii (Maca) on male rat sexual behavior
    Aaron Lentz
    Division of Urology, Department of Surgery, University of North Carolina, Chapel Hill, NC, USA
    J Sex Med 4:332-9; discussion 339-40. 2007
    ..For generations people of the rural community in Peru have used Lepidium meyenii Walpers (Maca), because of their belief that it improves fertility and sexual desire...
  49. ncbi request reprint Revision washout decreases implant capsule tissue culture positivity: a multicenter study
    Gerard D Henry
    Regional Urology, Shreveport, Louisiana, USA
    J Urol 179:186-90; discussion 190. 2008
    ..We investigated a larger series of patients for positive culture rates and evaluated implant capsule tissue culture rates before and after revision washout...
  50. ncbi request reprint Effects of testosterone on cognition and mood in male patients with mild Alzheimer's disease and elderly men
    Culley C Carson
    Curr Urol Rep 7:471-2. 2006
  51. ncbi request reprint The treatment of urinary tract infections and use of ciprofloxacin extended release
    Adam D Hickerson
    University of North Carolina, Division of Urology, 2140 Bioinformatics Building, Chapel Hill, NC27599 7235, USA
    Expert Opin Investig Drugs 15:519-32. 2006
    ..Economic considerations are also increasingly important and providing convenient and effective treatment leading to high clinical success decreases overall costs...
  52. ncbi request reprint Penile prosthesis cultures during revision surgery: a multicenter study
    Gerard D Henry
    Institute for Urologic Excellence, Van Buren, Arkansas, USA
    J Urol 172:153-6. 2004
    ..To explain the higher risk in revision surgery in this prospective study we cultured clinically uninfected prostheses requiring revision. Prosthesis pain was also investigated as a predictor of positive culture...
  53. ncbi request reprint Sexual dysfunction and lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH)
    Raymond C Rosen
    Department of Psychiatry, UMDNJ Robert Wood Johnson Medical School, 675 Hoes Lane, Piscataway, NJ 08854, USA
    Eur Urol 47:824-37. 2005
    ..For men with LUTS and sexual dysfunction, an appropriate integrated management approach, based on each patient's symptoms and outcome objectives, is warranted...
  54. ncbi request reprint Surgical treatment of Peyronie's disease
    Chris Tornehl
    Division of Urology, University of North Carolina Chapel Hill, 2140 Bio informatics Building, Chapel Hill, NC 27599 7235, USA
    Urol Clin North Am 32:479-85, vii. 2005
    ..This review is intended to share the experiences of other urologists in the surgical approach to PD...
  55. ncbi request reprint Efficacy of antibiotic impregnation of inflatable penile prostheses in decreasing infection in original implants
    Culley C Carson
    University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
    J Urol 171:1611-4. 2004
    ....
  56. ncbi request reprint Efficacy and safety of tadalafil in men with severe erectile dysfunction in tertiary care academic centers
    Culley C Carson
    Curr Urol Rep 6:437-8. 2005
  57. ncbi request reprint Revision washout decreases penile prosthesis infection in revision surgery: a multicenter study
    Gerard D Henry
    From Regional Urology, 255 Bert Kouns Street, Shreveport, Louisiana 71196, USA
    J Urol 173:89-92. 2005
    ..During revision surgery for noninfectious reasons we investigated washing out the implant space at revision surgery and using an antibiotic coated replacement prosthesis to determine if it would decrease subsequent infection rates...
  58. doi request reprint Lower urinary tract symptoms are associated with depressive symptoms in white, black and Hispanic men in the United States
    Edward O Laumann
    Department of Sociology, University of Chicago, Chicago, Illinois 60637, USA
    J Urol 180:233-40. 2008
    ..The relationship between lower urinary tract symptoms and depressive symptoms was assessed using data from the Male Attitudes Regarding Sexual Health study...